Seror, R., Nocturne, G., Lazure, T., Hendel-Chavez, H., Desmoulins, F., Belkhir, R., . . . Mariette, X. (2015). Low numbers of blood and salivary natural killer cells are associated with a better response to belimumab in primary Sjögren’s syndrome: Results of the BELISS study. Arthritis Res Ther.
Chicago-стиль цитированияSeror, Raphaèle, et al. "Low Numbers of Blood and Salivary Natural Killer Cells Are Associated With a Better Response to Belimumab in Primary Sjögren’s Syndrome: Results of the BELISS Study." Arthritis Res Ther 2015.
MLA-цитированиеSeror, Raphaèle, et al. "Low Numbers of Blood and Salivary Natural Killer Cells Are Associated With a Better Response to Belimumab in Primary Sjögren’s Syndrome: Results of the BELISS Study." Arthritis Res Ther 2015.